Details for Patent: 11,439,613
✉ Email this page to a colleague
Which drugs does patent 11,439,613 protect, and when does it expire?
Patent 11,439,613 protects DHIVY and is included in one NDA.
This patent has seven patent family members in six countries.
Summary for Patent: 11,439,613
Title: | Levodopa fractionated dose composition and use |
Abstract: | There is provided a convenient new treatment of Parkinson disease by a frequent administration of optimal levodopa doses mimicking a continuous intravenous or infusion treatment, thus mitigating motor complications; and a new carbidopa/levodopa pharmaceutical unit form providing said new treatment. |
Inventor(s): | Chase Thomas N, Clarence-Smith Kathleen E. |
Assignee: | AVION PHARMACEUTICALS. LLC |
Application Number: | US17219253 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,439,613
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Avion Pharms | DHIVY | carbidopa; levodopa | TABLET;ORAL | 214869-001 | Nov 12, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF PARKINSON'S DISEASE, POST-ENCEPHALITIC PARKINSONISM, AND SYMPTOMATIC PARKINSONISM THAT MAY FOLLOW CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,439,613
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | 112020017422 | ⤷ Sign Up | |||
Canada | 3095341 | ⤷ Sign Up | |||
China | 111954523 | ⤷ Sign Up | |||
European Patent Office | 3773532 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |